On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Shanghai Ninth People's Hospital

InstitutionResearch output, impact & collaborations

Shanghai Ninth People's Hospital is a institution indexed in ScholarIQ from OpenAlex.

What is known about Shanghai Ninth People's Hospital?

ScholarIQrecord summary

Shanghai Ninth People's Hospital is a research organisation in Shanghai, CN. OpenAlex records 24,426 works and 1,886,550 citations for it. 8,389 researchers list it as their most recent affiliation.

How many works does Shanghai Ninth People's Hospital have?

ScholarIQindexed works

Shanghai Ninth People's Hospital has 24,426 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Shanghai Ninth People's Hospital have?

ScholarIQcitation count

Shanghai Ninth People's Hospital has 1,886,550 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Shanghai Ninth People's Hospital?

ScholarIQresearcher count

Shanghai Ninth People's Hospital has 8,389 researchers in the ScholarIQ index.

What is the average h-index at Shanghai Ninth People's Hospital?

ScholarIQavg h-index

Shanghai Ninth People's Hospital has an average h-index of 68.5 in OpenAlex.

What is the ROR of Shanghai Ninth People's Hospital?

ScholarIQror

The ROR for Shanghai Ninth People's Hospital is on the source record.

What is the OpenAlex record for Shanghai Ninth People's Hospital?

ScholarIQopenalex

The OpenAlex for Shanghai Ninth People's Hospital is on the source record.

Who are the most-cited researchers behind Shanghai Ninth People's Hospital?

ScholarIQtop researchers by citations
1
Ming Zhan · Cancer-related molecular mechanisms research
219 works34,413 citations
2
Kerong Dai · Bone Tissue Engineering Materials
419 works19,006 citations

What are the most-cited papers on Shanghai Ninth People's Hospital?

ScholarIQmost cited works
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos, Henry G. Bone, Bente Langdahl, Kenneth G. Saag, Ian R. Reid, Douglas P. Kiel, Ilaria Cavallari, Marc P. Bonaca, Stephen D. Wiviott, Tobias De Villiers, Ling Xu, Kurt Lippuner, Toshitaka Nakamura, Jean‐Yves Reginster, Jose Adolfo Rodriguez-Portales, C. Roux, José Zanchetta, Cristiano A. F. Zerbini, Jeong‐Gun Park, KyungAh Im, Abby Cange, Laura T. Grip, Norman Heyden, Carolyn DaSilva, Dosinda Cohn, Rachid Massaad, Boyd B. Scott, Nadia Verbruggen, Deborah M. Gurner, Deborah L. Miller, Micki L Blair, Adam B. Polis, S. Aubrey Stoch, Arthur C. Santora, Antonio Lombardi, Albert Leung, Keith D. Kaufman, Marc S. Sabatine, C. Mautalén, Z. Man, José Zanchetta, C. Magaril, Philip N. Sambrook, Jean‐Yves Reginster, Piet Geusens, Stefan Goemaere, Ben Hur Albergaria, Cristiano A. F. Zerbini, Marise Lazaretti Castro, Luiz Henrique de Gregório, Румен Стоилов, Anna-Maria I Borissova, Kiril Hristov Hristozov, Nataliya Temelkova, Ivona Daskalova, Stefka I Kuzmanova, Daniela Yaneva-Bichovska, Anastas Batalov, Pablo Riedemann, José Adolfo Rodríguez Portales, Hai Tang, Han-min Zhu, Zhenlin Zhang, Aijun Chao, Yali Hu, Zhiming Liu, Ju-ming Lu, Ming-cai Qiu, Xin Gao, Shaofen Zhang, Ling Xu, Weibo Xia, Eryuan Liao, Wenying Yang, Wen Wu, Kerong Dai, Renming Hu, Hai Tang, Juan José Jaller, Francisco Cabal, José Fernando Molina, Carlos Curé, Hernan Yupanqui-Lozno, Philippe Chalem, John Londoño, Maurício Abello, Edgardo D Tobias, William Otero, Tatjana Nikolić, Blazenka Miskic, J Štěpán, Václav Vyskočil, Libor Novosád, Jan Slesinger, Pavel Novosad, Erika Vlckova, Ladislav Bortlík, Eva Dokoupilová
The Lancet Diabetes & Endocrinology. 2019170 CitationsOPEN ACCESS

How much of the research on Shanghai Ninth People's Hospital is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
100%
Hybrid
0%
Bronze
0%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial